Artificial Intelligence presents the pharmaceutical industry with the opportunity to solve problems previously unsolvable with simple data analysis. Through integrated intelligence, AI is able to perform specific analysis faster and more accurately thereby reducing costs while increasing productivity. AI will increase the impact of Connected Pharma contributing to economic growth of the industry
while augmenting the workplace for greater efficacy.
Many processes along the pharma lifecycle are still dominated by manual reviews. The problem
with manual reviews is they are obviously time-consuming, prone to user error and are not
future-proofed. Manual reviews are based on a static point-in-time and do not consider new data or information. New information requires a new review. AI operates in real-time constantly incorporating new inputs offering complete, up to date information to healthcare providers.
Not only are automated processes more efficient but they tend to be more accurate, saving
pharmaceutical companies both time and money. Beyond these basic benefits, AI is capable of seeing patterns that even trained professionals might miss. Further, it supplies
real-time actionable insights filling the potential knowledge gap of care providers.
Read the White Paper – ARTIFICIAL INTELLIGENCE: NEXT FRONTIER FOR CONNECTED PHARMA
Unlock the future of drug intelligence
From commercial excellence to faster clinical trials, embrace big data and unlock its power to boost drug development, manage a sales force and monetize marketing initiatives.